Add to ORKGComplementary and alternative medicines (CAMs) are increasingly being utilized in the pediatric cancer population, despite unproven risks and benefits, and significant additional cost of treatment. Objective: To identify the prevalence of CAM use and the most frequently utilized CAMs, and to examine the physiologic impact of CAM in pediatric cancer patients undergoing chemotherapy. Additional objectives included identifying the cost associated with CAM, and the rationale for CAM usage
The survival rates of infants born preterm with extremely low birth weight (ELBW ≤ 1000 g) have grad...
In this review we have showcased the preclinical development of original amphiphilic nanomaterials ...
This is the final version. Available on open access from MDPI via the DOI in this recordInvasive can...
There are many medications indicated for the treatment of CD. Selection should aim to balance side-e...
Patients with cancer are at particularly high risk for malnutrition because both the disease and its...
Information concerning the student outcomes of interdisciplinary education is limited. The purpose o...
peer reviewedMHC class I–associated peptides (MAPs), collectively referred to as the immunopeptidome...
Background and Objectives: With more and more cases emerging outside central and west African coun...
OBJECTIVE: The objective of this evidence based medicine review is to determine whether or not Botul...
In the hippocampus GABAergic local circuit inhibitory interneurons represent only ~10–15% of the tot...
Recently, the President’s Cancer Panel [2008-2009] protested that preventive action is not ta...
Advanced practice and primary care providers are increasingly managing the ever-growing population o...
DATA AVAILABILITY STATEMENT : Data restricted due to ethical considerations but reasonable requests ...
Secondary lower-limb lymphedema can develop following treatment for gynecological cancers, and has d...
This is the author accepted manuscript. The final version is available from American Physiological S...
The survival rates of infants born preterm with extremely low birth weight (ELBW ≤ 1000 g) have grad...
In this review we have showcased the preclinical development of original amphiphilic nanomaterials ...
This is the final version. Available on open access from MDPI via the DOI in this recordInvasive can...
There are many medications indicated for the treatment of CD. Selection should aim to balance side-e...
Patients with cancer are at particularly high risk for malnutrition because both the disease and its...
Information concerning the student outcomes of interdisciplinary education is limited. The purpose o...
peer reviewedMHC class I–associated peptides (MAPs), collectively referred to as the immunopeptidome...
Background and Objectives: With more and more cases emerging outside central and west African coun...
OBJECTIVE: The objective of this evidence based medicine review is to determine whether or not Botul...
In the hippocampus GABAergic local circuit inhibitory interneurons represent only ~10–15% of the tot...
Recently, the President’s Cancer Panel [2008-2009] protested that preventive action is not ta...
Advanced practice and primary care providers are increasingly managing the ever-growing population o...
DATA AVAILABILITY STATEMENT : Data restricted due to ethical considerations but reasonable requests ...
Secondary lower-limb lymphedema can develop following treatment for gynecological cancers, and has d...
This is the author accepted manuscript. The final version is available from American Physiological S...
The survival rates of infants born preterm with extremely low birth weight (ELBW ≤ 1000 g) have grad...
In this review we have showcased the preclinical development of original amphiphilic nanomaterials ...
This is the final version. Available on open access from MDPI via the DOI in this recordInvasive can...